复发性腹泻的治疗
Treatment of Recurrent Diarrhea.
作者信息
Huebner Elizabeth S, Surawicz Christina M
机构信息
Dr. Huebner is a Fellow in the Division of Gastroenterology at the University of Washington School of Medicine in Seattle, where Dr. Surawicz is Professor of Medicine, Section Chief in Gastroenterology at the Harborview Medical Center, and Assistant Dean for Faculty Development.
出版信息
Gastroenterol Hepatol (N Y). 2006 Mar;2(3):203-208.
Abstract
Treatment of recurrent -associated diarrhea can be challenging. Once patients develop recurrent disease, further episodes are common and can continue for months or even a year or more. Treatment begins with a repeat standard 10-day course of antibiotics, followed by tapering and/or pulsing of the antibiotic dose. Probiotics can also be useful, particularly the nonpathogenic yeast . Stool reconstitution via fecal enemas, colonoscopy, and nasogastric tubes have been performed to restore normal colonic flora. Additional approaches under investigation, such as vaccination against , show encouraging preliminary results.
摘要
复发性相关腹泻的治疗可能具有挑战性。一旦患者出现复发性疾病，进一步发作很常见，可能持续数月甚至一年或更长时间。治疗首先是重复标准的10天抗生素疗程，然后逐渐减少和/或脉冲式给予抗生素剂量。益生菌也可能有用，特别是非致病性酵母。已通过粪便灌肠、结肠镜检查和鼻胃管进行粪便重建以恢复正常结肠菌群。正在研究的其他方法，如针对……的疫苗接种，显示出令人鼓舞的初步结果。
相似文献
1
Treatment of Recurrent Diarrhea.复发性腹泻的治疗
Gastroenterol Hepatol (N Y). 2006 Mar;2(3):203-208.
2
The effect of probiotics on Clostridium difficile diarrhea.益生菌对艰难梭菌腹泻的影响。
Am J Gastroenterol. 2000 Jan;95(1 Suppl):S11-3. doi: 10.1016/s0002-9270(99)00809-6.
3
Treatment of recurrent Clostridium difficile-associated disease.复发性艰难梭菌相关性疾病的治疗
Nat Clin Pract Gastroenterol Hepatol. 2004 Nov;1(1):32-8. doi: 10.1038/ncpgasthep0018.
4
Recurrent Clostridium difficile colitis. Tackling a tenacious nosocomial infection.复发性艰难梭菌结肠炎。应对一种顽固的医院感染。
Postgrad Med. 2002 Nov;112(5):53-4, 57-8, 65 passim. doi: 10.3810/pgm.2002.11.1345.
5
Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.用于艰难梭菌相关性腹泻的益生菌：聚焦鼠李糖乳杆菌GG和布拉酵母菌。
Ann Pharmacother. 2007 Jul;41(7):1212-21. doi: 10.1345/aph.1K110. Epub 2007 Jun 26.
6
Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.益生菌用于预防抗生素相关性腹泻和艰难梭菌腹泻。
J Clin Gastroenterol. 2006 Mar;40(3):249-55. doi: 10.1097/00004836-200603000-00017.
7
The Efficacy of a Mix of Probiotics ( LMG P-27481 and GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial.益生菌组合（LMG P - 27481和GG ATCC 53103）预防住院患者抗生素相关性腹泻和感染的疗效：单中心、开放标签、随机试验
Microorganisms. 2024 Jan 18;12(1):198. doi: 10.3390/microorganisms12010198.
8
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.用万古霉素和布拉氏酵母菌治疗复发性艰难梭菌结肠炎。
Am J Gastroenterol. 1989 Oct;84(10):1285-7.
9
Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii.
Dig Dis Sci. 1990 Jul;35(7):897-901. doi: 10.1007/BF01536805.
10
Treatment and prevention of antibiotic associated diarrhea.抗生素相关性腹泻的治疗与预防
Int J Antimicrob Agents. 2000 Dec;16(4):521-6. doi: 10.1016/s0924-8579(00)00293-4.
引用本文的文献
1
sp. SNUL2 as potential probiotics with broad-spectrum antimicrobial activities.将sp. SNUL2作为具有广谱抗菌活性的潜在益生菌。
Heliyon. 2024 Mar 25;10(7):e28481. doi: 10.1016/j.heliyon.2024.e28481. eCollection 2024 Apr 15.
2
Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.造血干细胞移植和血液恶性肿瘤患者中的艰难梭菌感染。
Infect Dis Clin North Am. 2019 Jun;33(2):447-466. doi: 10.1016/j.idc.2019.02.010.
3
Fecal Microbiota Transplantation for the Management of Infection.粪便微生物移植在感染管理中的应用。
Surg Infect (Larchmt). 2018 Nov/Dec;19(8):785-791. doi: 10.1089/sur.2018.221. Epub 2018 Oct 9.
4
Fecal microbiota transplantation for the treatment of Clostridium difficile infection.粪便微生物群移植治疗艰难梭菌感染
J Hosp Med. 2016 Jan;11(1):56-61. doi: 10.1002/jhm.2449. Epub 2015 Sep 7.
5
Fecal microbiota transplantation for the management of Clostridium difficile infection.粪菌移植用于艰难梭菌感染的治疗
Infect Dis Clin North Am. 2015 Mar;29(1):109-22. doi: 10.1016/j.idc.2014.11.009.
6
Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.肠道微生物群与粪便微生物群移植在胃肠道疾病中的疗效
Gastroenterol Hepatol (N Y). 2014 Apr;10(4):230-7.
7
Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection.医生对使用粪便微生物群移植治疗复发性艰难梭菌感染的态度。
Can J Gastroenterol Hepatol. 2014 Jun;28(6):319-24. doi: 10.1155/2014/403828. Epub 2014 Apr 9.
8
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.非达霉素治疗艰难梭菌感染：最新证据与临床指南
Ther Adv Chronic Dis. 2014 Mar;5(2):69-84. doi: 10.1177/2040622313511285.
9
Therapeutic faecal microbiota transplantation: current status and future developments.治疗性粪菌移植：现状与未来发展。
Curr Opin Gastroenterol. 2014 Jan;30(1):97-105. doi: 10.1097/MOG.0000000000000027.
10
Fecal transplantation for the treatment of recurrent clostridium difficile infection.粪便移植治疗复发性艰难梭菌感染
N Am J Med Sci. 2013 Jun;5(6):339-43. doi: 10.4103/1947-2714.114163.
本文引用的文献
1
An epidemic, toxin gene-variant strain of Clostridium difficile.一种艰难梭菌的流行、毒素基因变异菌株。
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
2
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.艰难梭菌相关性腹泻的多机构主要克隆性暴发，发病率和死亡率高。
N Engl J Med. 2005 Dec 8;353(23):2442-9. doi: 10.1056/NEJMoa051639. Epub 2005 Dec 1.
3
Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.三级医疗学术医院住院患者艰难梭菌相关性腹泻的分析
Diagn Microbiol Infect Dis. 2005 Jun;52(2):153-5. doi: 10.1016/j.diagmicrobio.2004.12.015.
4
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.
Gastroenterology. 2005 Mar;128(3):764-70. doi: 10.1053/j.gastro.2004.11.004.
5
Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.富含牛抗体的乳清用于辅助预防艰难梭菌相关性腹泻复发：临床前及初步临床数据
J Med Microbiol. 2005 Feb;54(Pt 2):197-205. doi: 10.1099/jmm.0.45773-0.
6
Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea.托利霉素（一种预防抗生素相关性腹泻的聚阴离子药物）的毒素结合情况。
Biophys J. 2004 Jul;87(1):534-9. doi: 10.1529/biophysj.104.041277.
7
Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea.静脉注射免疫球蛋白治疗复发性艰难梭菌腹泻的描述性研究。
J Antimicrob Chemother. 2004 May;53(5):882-4. doi: 10.1093/jac/dkh176. Epub 2004 Apr 8.
8
Active and passive immunization against Clostridium difficile diarrhea and colitis.针对艰难梭菌腹泻和结肠炎的主动免疫和被动免疫。
Vaccine. 2004 Feb 17;22(7):848-56. doi: 10.1016/j.vaccine.2003.11.030.
9
Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.植物乳杆菌299v治疗复发性艰难梭菌相关性腹泻：一项双盲、安慰剂对照试验
Scand J Infect Dis. 2003;35(6-7):365-7. doi: 10.1080/00365540310010985.
10
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.对从18例复发性艰难梭菌相关性腹泻病例中分离出的艰难梭菌菌株进行分子分析。
J Clin Microbiol. 2003 Jul;41(7):3413-4. doi: 10.1128/JCM.41.7.3413-3414.2003.
Zotero 插件